A detailed history of Cary Street Partners Investment Advisory LLC transactions in Biogen Inc. stock. As of the latest transaction made, Cary Street Partners Investment Advisory LLC holds 1,901 shares of BIIB stock, worth $283,287. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,901
Previous 1,844 3.09%
Holding current value
$283,287
Previous $427,000 13.82%
% of portfolio
0.01%
Previous 0.02%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

BUY
$189.07 - $236.8 $10,776 - $13,497
57 Added 3.09%
1,901 $368,000
Q2 2024

Jul 22, 2024

BUY
$190.52 - $236.72 $3,619 - $4,497
19 Added 1.04%
1,844 $427,000
Q1 2024

Apr 30, 2024

SELL
$212.02 - $267.71 $1,696 - $2,141
-8 Reduced 0.44%
1,825 $393,000
Q4 2023

Feb 07, 2024

BUY
$222.59 - $267.94 $408,007 - $491,134
1,833 New
1,833 $474,000
Q3 2023

Nov 13, 2023

BUY
$253.3 - $285.89 $11,398 - $12,865
45 Added 2.36%
1,955 $502,000
Q4 2022

Feb 14, 2023

SELL
$252.44 - $306.72 $3,281 - $3,987
-13 Reduced 0.68%
1,910 $528,000
Q3 2022

Nov 14, 2022

BUY
$194.69 - $268.46 $40,300 - $55,571
207 Added 12.06%
1,923 $513,000
Q2 2022

Aug 15, 2022

BUY
$187.54 - $223.02 $321,818 - $382,702
1,716 New
1,716 $350,000
Q3 2021

Nov 15, 2021

SELL
$282.99 - $369.05 $33,958 - $44,286
-120 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$259.0 - $414.71 $1,295 - $2,073
5 Added 4.35%
120 $42,000
Q1 2021

May 17, 2021

BUY
$242.95 - $284.63 $27,939 - $32,732
115 New
115 $32,000
Q4 2020

Feb 12, 2021

SELL
$236.26 - $355.63 $1.13 Million - $1.69 Million
-4,764 Closed
0 $0
Q3 2020

Nov 12, 2020

BUY
$264.77 - $305.71 $1.26 Million - $1.46 Million
4,764 New
4,764 $1.35 Million

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $21.5B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Cary Street Partners Investment Advisory LLC Portfolio

Follow Cary Street Partners Investment Advisory LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cary Street Partners Investment Advisory LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cary Street Partners Investment Advisory LLC with notifications on news.